Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has filed a routine compliance certificate under SEBI's Regulation 74(5) for the quarter ended June 30, 2025. This regulation requires the company's registrar and share transfer agent to confirm that all share certificates received for dematerialization (conversion from physical to electronic form) during the quarter have been properly processed and credited to investors' demat accounts. No specific share counts, financial numbers, or material business updates are disclosed in this filing. It is a standard quarterly submission required from all listed companies, indicating that demat-related operations ran smoothly during the period.
No impact on shareholders or stock price. This is a routine regulatory compliance filing with no material information, business update, or corporate action involved.